KAREN HEMMER: Open Payments
NPI 1144461047 · PORT CLINTON, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,297 in 133 payments from 26 companies in 2025. Trend: 2023 $2,090 · 2024 $2,098 · 2025 $2,297
Food & beverage: $2,297
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 22 | $348 |
| AstraZeneca Pharmaceuticals LP | 7 | $284 |
| ABBVIE INC. | 16 | $245 |
| Bayer Healthcare Pharmaceuticals Inc. | 13 | $187 |
| Novo Nordisk Inc | 15 | $165 |
| PFIZER INC. | 11 | $150 |
| Abbott Laboratories | 7 | $143 |
| Otsuka America Pharmaceutical, Inc. | 5 | $100 |
| Phathom Pharmaceuticals, Inc. | 3 | $64 |
| Lilly USA, LLC | 4 | $63 |
Products named: AUSTEDO XR, FARXIGA, Kerendia, VRAYLAR, REXULTI, FREESTYLE LIBRE 3, Ozempic, NURTEC ODT.
Industry payments across OH — which companies pay providers there.
